Vitamin B12 Replacement for Stroke with B12 Deficiency and Elevated Homocysteine
For this 36-year-old woman with stroke, documented B12 deficiency, and elevated homocysteine (18 µmol/L), initiate intramuscular vitamin B12 1000 µg (1 mg) every other day for one week, then 1000 µg monthly for life. 1, 2
Rationale for Aggressive Parenteral Therapy
Your patient has clinical B12 deficiency with neurological manifestations (stroke involving cerebellum, occipital, and frontal lobes) plus elevated homocysteine >15 µmol/L, which meets criteria for urgent treatment. The guidelines are clear: patients with clinical deficiency and neurological symptoms require parenteral therapy, not oral supplementation 1.
Why Intramuscular Over Oral?
- Neurological involvement mandates parenteral therapy - When B12 deficiency presents with neurological symptoms (your patient has stroke), oral supplementation is insufficient even if absorption is intact 3
- The loading dose of 1000 µg every other day for one week ensures rapid tissue saturation 1, 2
- Monthly maintenance with 1000 µg (not the older 3-monthly regimen) is necessary to prevent recurrence of clinical manifestations 1
Addressing the Elevated Homocysteine
Your patient's homocysteine of 18 µmol/L is elevated (normal <15 µmol/L) and represents a modifiable stroke risk factor. B vitamin supplementation reduces stroke risk by approximately 43% in patients with elevated homocysteine 4. The target should be homocysteine <10 µmol/L for optimal vascular protection 4.
Add Folic Acid
Supplement with folic acid 1-5 mg daily orally in addition to B12 5, 6. The combination of B12 and folic acid is more effective than B12 alone for lowering homocysteine - folic acid provides an additional 25-30% reduction in homocysteine levels 6.
Critical Pitfall to Avoid
Never give folic acid without B12 in a patient with B12 deficiency and neurological symptoms - folic acid can correct the hematological abnormalities while allowing neurological deterioration to progress 5. Your patient already has neurological involvement (stroke), making this particularly dangerous.
Monitoring and Follow-up
- Recheck serum B12 and homocysteine at 3 months to verify normalization 5
- Target homocysteine <10 µmol/L 4
- Continue monthly B12 injections indefinitely - this is lifelong therapy 1, 2
- If homocysteine remains elevated despite B12 and folic acid, consider adding vitamin B6 (pyridoxine 50-250 mg/day) 6
Why Not Oral B12?
While oral B12 (1200-2400 µg daily) can be effective for dietary deficiency 1, parenteral therapy remains the standard for patients with neurological manifestations 1, 7. Recent evidence suggests up to 50% of patients with B12 deficiency require individualized injection frequencies (ranging from twice weekly to monthly) to remain symptom-free 7. Given your patient's young age (36 years) and severe presentation (multi-territory stroke), starting with the most aggressive evidence-based regimen is appropriate.
Form of B12 Matters
If available, use methylcobalamin or hydroxycobalamin instead of cyanocobalamin 4. Cyanocobalamin requires conversion and may be less effective, particularly in patients with genetic polymorphisms affecting folate metabolism. However, if only cyanocobalamin is available (as is common in the United States), use it rather than delaying treatment 8.